SCHEMBL6739737

SCHEMBL6739737

CC(C)CCn1c(=O)c(C2=NS(=O)(=O)c3ccccc3N2)c(O)c2cc(OCc3ccccc3)ccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.59
HSD17B10 Q99714 1/20 0.59
CYP2C9 P11712 3/20 0.54
NR1I2 O75469 1/20 0.54
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAOB P27338 1/20 0.38
USP2 O75604 1/20 0.38
HTR3A P46098 1/20 0.36
LTB4R Q15722 1/20 0.35
LTB4R2 Q9NPC1 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
AS3MT Q9HBK9 1/20 0.35
ADAM17 P78536 2/20 0.34
CHEK1 O14757 1/20 0.34
WEE1 P30291 1/20 0.34
MMP9 P14780 1/20 0.34
MMP1 P03956 1/20 0.34
SRD5A2 P31213 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236659 0.95 MAPK1 (0.57) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6240041 0.89 MAPK1 (0.59) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6236709 0.88 MAPK1 (0.57) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6235652 0.88 MAPK1 (0.68) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6235658 0.87 MAPK1 (0.57) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6737830 0.85 MAPK1 (0.61) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6232411 0.85 MAPK1 (0.67) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6739082 0.85 MAPK1 (0.67) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6235598 0.85 MAPK1 (0.56) MAPK1HSD17B10CYP2C9NR1I2MEN1
SCHEMBL6234490 0.85 MAPK1 (0.64) MAPK1HSD17B10CYP2C9NR1I2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1535151-A Novel anti-infectives ʷ��˿�������ȳ�ķ���޹�˾ 2004-10-06 CN claimed
US-20040147739-A1 Novel anti-infectives SMITHKLINE BEECHAM CORPORATION 2004-07-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147739-A1 Novel anti-infectives RPL5, RPL7, RPL35 MAPK1 3699/4885HSD17B10 1428/4885CYP2C9 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.